The Effectiveness and Tolerability of Preformed Growth Factors Vehiculated Through Iontophoresis on Patients with Androgenetic Alopecia and Telogen Effluvium: A Clinical Study

Background: Androgenetic alopecia is characterized by a progressive miniaturization of hair follicles in a pattern distribution in genetically predisposed individuals. The efficacy of conventional therapies is variable, therefore there is a need for adjuvant and newer treatment modalities to provid...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aurora Maria Alessandrini, Francesca Bruni, Bianca Maria Piraccini, Michela Starace
Formato: article
Lenguaje:EN
Publicado: Mattioli1885 2021
Materias:
Acceso en línea:https://doaj.org/article/20a78b6b9bec495183c2ee073db1bf92
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:20a78b6b9bec495183c2ee073db1bf92
record_format dspace
spelling oai:doaj.org-article:20a78b6b9bec495183c2ee073db1bf922021-11-17T08:27:50ZThe Effectiveness and Tolerability of Preformed Growth Factors Vehiculated Through Iontophoresis on Patients with Androgenetic Alopecia and Telogen Effluvium: A Clinical Study10.5826/dpc.1103a822160-9381https://doaj.org/article/20a78b6b9bec495183c2ee073db1bf922021-05-01T00:00:00Zhttp://dpcj.org/index.php/dpc/article/view/1646https://doaj.org/toc/2160-9381 Background: Androgenetic alopecia is characterized by a progressive miniaturization of hair follicles in a pattern distribution in genetically predisposed individuals. The efficacy of conventional therapies is variable, therefore there is a need for adjuvant and newer treatment modalities to provide faster and better outcomes. Objectives: Evaluation of the efficacy and tolerability of a combined therapy: preformed growth factors vehiculated through iontophoresis in patients with androgenetic alopecia and associated telogen effluvium, to obtain faster hair regrowth. Materials and Methods: Treatment was performed between June 2018 and June 2019 on 60 patients with androgenetic alopecia and associated telogen effluvium. Each patient underwent 4 sessions in total, each session was performed every 3 weeks. Global photography and trichoscopy were collected at every session of therapy. All patients filed out a self-assessment questionnaire. Results: Results were very promising, with improvement of hair density and thickening of the hair shaft diameter in most of patients seen with both global photography and trichoscopy. All patients were satisfied of the clinical result and reported a complete reduction in hair loss. No serious adverse side effects were reported. Conclusions: The use of growth factors associated with iontophoresis technique is a useful treatment for treating and preventing androgenetic alopecia. In addition, in case of associated telogen effluvium, this technique allows for an early stop of hair shedding, especially when cosmetic procedures do not provide satisfactory results in patients. Aurora Maria AlessandriniFrancesca BruniBianca Maria Piraccini Michela StaraceMattioli1885articleiontophoresisandrogenetic alopeciatelogen effluviumgrowth factorsscalp disordersphysical therapyDermatologyRL1-803ENDermatology Practical & Conceptual (2021)
institution DOAJ
collection DOAJ
language EN
topic iontophoresis
androgenetic alopecia
telogen effluvium
growth factors
scalp disorders
physical therapy
Dermatology
RL1-803
spellingShingle iontophoresis
androgenetic alopecia
telogen effluvium
growth factors
scalp disorders
physical therapy
Dermatology
RL1-803
Aurora Maria Alessandrini
Francesca Bruni
Bianca Maria Piraccini
Michela Starace
The Effectiveness and Tolerability of Preformed Growth Factors Vehiculated Through Iontophoresis on Patients with Androgenetic Alopecia and Telogen Effluvium: A Clinical Study
description Background: Androgenetic alopecia is characterized by a progressive miniaturization of hair follicles in a pattern distribution in genetically predisposed individuals. The efficacy of conventional therapies is variable, therefore there is a need for adjuvant and newer treatment modalities to provide faster and better outcomes. Objectives: Evaluation of the efficacy and tolerability of a combined therapy: preformed growth factors vehiculated through iontophoresis in patients with androgenetic alopecia and associated telogen effluvium, to obtain faster hair regrowth. Materials and Methods: Treatment was performed between June 2018 and June 2019 on 60 patients with androgenetic alopecia and associated telogen effluvium. Each patient underwent 4 sessions in total, each session was performed every 3 weeks. Global photography and trichoscopy were collected at every session of therapy. All patients filed out a self-assessment questionnaire. Results: Results were very promising, with improvement of hair density and thickening of the hair shaft diameter in most of patients seen with both global photography and trichoscopy. All patients were satisfied of the clinical result and reported a complete reduction in hair loss. No serious adverse side effects were reported. Conclusions: The use of growth factors associated with iontophoresis technique is a useful treatment for treating and preventing androgenetic alopecia. In addition, in case of associated telogen effluvium, this technique allows for an early stop of hair shedding, especially when cosmetic procedures do not provide satisfactory results in patients.
format article
author Aurora Maria Alessandrini
Francesca Bruni
Bianca Maria Piraccini
Michela Starace
author_facet Aurora Maria Alessandrini
Francesca Bruni
Bianca Maria Piraccini
Michela Starace
author_sort Aurora Maria Alessandrini
title The Effectiveness and Tolerability of Preformed Growth Factors Vehiculated Through Iontophoresis on Patients with Androgenetic Alopecia and Telogen Effluvium: A Clinical Study
title_short The Effectiveness and Tolerability of Preformed Growth Factors Vehiculated Through Iontophoresis on Patients with Androgenetic Alopecia and Telogen Effluvium: A Clinical Study
title_full The Effectiveness and Tolerability of Preformed Growth Factors Vehiculated Through Iontophoresis on Patients with Androgenetic Alopecia and Telogen Effluvium: A Clinical Study
title_fullStr The Effectiveness and Tolerability of Preformed Growth Factors Vehiculated Through Iontophoresis on Patients with Androgenetic Alopecia and Telogen Effluvium: A Clinical Study
title_full_unstemmed The Effectiveness and Tolerability of Preformed Growth Factors Vehiculated Through Iontophoresis on Patients with Androgenetic Alopecia and Telogen Effluvium: A Clinical Study
title_sort effectiveness and tolerability of preformed growth factors vehiculated through iontophoresis on patients with androgenetic alopecia and telogen effluvium: a clinical study
publisher Mattioli1885
publishDate 2021
url https://doaj.org/article/20a78b6b9bec495183c2ee073db1bf92
work_keys_str_mv AT auroramariaalessandrini theeffectivenessandtolerabilityofpreformedgrowthfactorsvehiculatedthroughiontophoresisonpatientswithandrogeneticalopeciaandtelogeneffluviumaclinicalstudy
AT francescabruni theeffectivenessandtolerabilityofpreformedgrowthfactorsvehiculatedthroughiontophoresisonpatientswithandrogeneticalopeciaandtelogeneffluviumaclinicalstudy
AT biancamariapiraccini theeffectivenessandtolerabilityofpreformedgrowthfactorsvehiculatedthroughiontophoresisonpatientswithandrogeneticalopeciaandtelogeneffluviumaclinicalstudy
AT michelastarace theeffectivenessandtolerabilityofpreformedgrowthfactorsvehiculatedthroughiontophoresisonpatientswithandrogeneticalopeciaandtelogeneffluviumaclinicalstudy
AT auroramariaalessandrini effectivenessandtolerabilityofpreformedgrowthfactorsvehiculatedthroughiontophoresisonpatientswithandrogeneticalopeciaandtelogeneffluviumaclinicalstudy
AT francescabruni effectivenessandtolerabilityofpreformedgrowthfactorsvehiculatedthroughiontophoresisonpatientswithandrogeneticalopeciaandtelogeneffluviumaclinicalstudy
AT biancamariapiraccini effectivenessandtolerabilityofpreformedgrowthfactorsvehiculatedthroughiontophoresisonpatientswithandrogeneticalopeciaandtelogeneffluviumaclinicalstudy
AT michelastarace effectivenessandtolerabilityofpreformedgrowthfactorsvehiculatedthroughiontophoresisonpatientswithandrogeneticalopeciaandtelogeneffluviumaclinicalstudy
_version_ 1718425786300497920